Julie Bruneau | OMICS International
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2384

Journal of Addiction Research & Therapy received 2384 citations as per google scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Julie Bruneau

Proffessor Department of Family Medicine, Research Center,Center Hospitalier de l, Universitie de Montreal          


Dr Julie Bruneau is a clinical researcher and Professor in the Department of Family Medicine at the University of Montreal. As a clinician, she is recognized as a leader in the development of addiction medicine in Canada. She was one of the founding member of the Canadian Society of Addiction Medicine, and implemented the largest University-based Addiction Medicine Facility in Quebec

Research Interest

For the past twenty years, she has conducted epidemiological research among active injecting drug users (IDU), and published her work in high-impact journals. Her research accomplishments have significantly contributed to a better understanding of the dynamics of HIV and HCV transmission among IDUs. Her work on the relation between syringe access and HIV transmission, albeit controversial at times, directly influenced changes in prevention strategies to better address injector needs nationally and around the world. Recently, she has expanded her research program to examine the impact of various approaches including treatment and motivational interviewing, on the behaviors and quality of life of active injection drug users (IDU). She is also a member of the research team on the development of a vaccine against HCV, led by Drs Tyrrell and Houghton.